January 02, 2020
Article
Novadoz Pharmaceuticals, who markets the product, has commenced shipping of the drug, available in bottles of 30 tablets.
February 22, 2019
Febuxostat was FDA-approved in 2009 to treat gout in adults.
November 16, 2018
The statement is intended to serve as a discussion guide for the risk factors, diagnosis, treatment and prevention of the disease.
November 15, 2018
Nonsteroidal anti-inflammatory drugs should be used as the first line treatment for acute gout.
February 24, 2018
The FDA has approved Duzallo (lesinurad and allopurinol; Ironwood Pharmaceuticals, Inc) for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid (sUA) levels with a medically appropriate daily dose of allopurinol alone.
November 16, 2017
Febuxostat (Uloric) could escalate heart-related and all-cause mortality.
November 04, 2017
Study finds high unmet need among patients with uncontrolled gout.
August 22, 2017
The FDA has approved a new fixed-dose combination treatment for hyperuricemia in patients with uncontrolled gout.
August 21, 2017
Duzallo (lesinurad and allopurinol) may result in better disease control among patients with gout.
July 06, 2017
Lesinurad plus febuxostat provides dual mechanisms of action to lower urate levels for patients with tophaceous gout.
